Courses

This CME/CE activity will highlight recent data for the treatment and management of acute leukemia, including information presented at the American Society of Hematology Annual Meeting in Orlando, Florida. The expert faculty, chaired by Eytan M. Stein, MD, will first discuss the pathophysiology of acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), reviewing diagnostic criteria and comorbidities. Current clinical ...
View Course

This CME/CE program, derived from content presented at the 2019 American Heart Association Scientific Sessions in Philadelphia, Pennsylvania, will highlight advanced strategies for improving cardiovascular disease (CVD) outcomes in patients with chronic coronary artery disease (CAD) and peripheral artery disease (PAD). The expert faculty, chaired by Dr. Christopher P. Cannon, will first provide an introduction and state of the science ...
View Course

This CME program will highlight recent advances in intensive antiplatelet therapy to improve outcomes in patients with acute coronary syndrome (ACS). The expert faculty, led by Dr. Christopher P. Cannon, will review platelet inhibition science as well as unmet needs in ACS. Following, recent clinical trial data, including outcomes data, will be analyzed and clinical relevance debated in an interactive ...
View Course

This continuing education activity is derived from content presented at the 2019 ASHP Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada. The program will highlight recent advances in antiplatelet therapeutics for acute coronary syndrome. The expert faculty will analyze current guidelines and provide insight into best approaches for developing effective patient-specific treatment plans that include the clinical pharmacy team ...
View Course

This CME activity will review recent advances in the improvement CGRP Inhibitors & Therapeutic Implementation as presented at the American Headache Society (AHS) 2019 Philadelphia, PA. The expert faculty will discuss the immunologic and pathogenic mechanisms of CGRP as well as strategies for implementation of novel CGRP inhibitors into patient-specific treatments. The faculty will also analyze safety, efficacy, and tolerability ...
View Course

This CME activity will review recent advances in the management of patients with Inflammatory Bowel Disease (IBD) as presented at the Digestive Disease Week (DDW) 2019 in San Diego, CA. The expert faculty will discuss the science of the inflammatory cascade as well as review recent clinical trial data for IBD treatments. The faculty will also discuss strategies for utilizing ...
View Course

This CME program was derived from content presented at the Eastern Pulmonary Conference 2019 Annual Meeting in Palm Beach, Florida. The expert faculty, Dr. Sidney Braman, will review the pathophysiology and disease burden of asthma to improve patient management. Next, he will delve into the subtypes of asthma and analyze clinical data of novel pharmacotherapies to determine treatment efficacy. Dr ...
View Course

This CME program was derived from content presented at the Eastern Pulmonary Conference 2019 Annual Meeting in Palm Beach, Florida. Drs. Charles Powell and Julie Barta will review the most recent discoveries about non-small cell lung cancer (NSCLC) tumor microenvironment as well as strategies for the treatment and management of NSCLC. The expert faculty will review strategies to incorporate the ...
View Course

This CME/CE program, derived from content presented at the 2019 American Heart Association Scientific Sessions in Philadelphia, Pennsylvania, will highlight new therapeutic options for acute and chronic hyperkalemia. The expert faculty, led by Dr. Charles V. Pollack, Jr., will first provide an introduction and state of the science of hyperkalemia, including risk assessment and disease burden. Recent trial data of ...
View Course

This continuing education program will highlight recent advances in the treatment and management of breast cancer, with a focus on HER2-targeted therapy. The expert faculty will review the current treatment landscape for both early stage and metastatic breast cancer. Recent clinical trial data of emerged and emerging agents, particularly best practices for optimizing HER2-targeted therapy continuing into the adjuvant setting, ...
View Course